Certain diabetes drugs linked to lower risk of kidney stones and gout
SGLT-2 inhibitors may simultaneously tackle kidney stones and gout flare-ups in patients with type 2 diabetes, say researchers Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of recurrent kidney stones and gout flare-ups, finds a study from ...